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BACKGROUND: Environmental manganese exposure has been associated with adverse neurodevelopmental outcomes among school-aged children; yet,
few studies have evaluated prenatal exposure.
OBJECTIVES: Our study examines associations between prenatal manganese concentrations and placental transfer of manganese with neurodevelop-
ment in 224 2-y-old children residing near the Tar Creek Superfund Site.
METHODS:We collected maternal and cord blood at delivery, measured manganese using inductively coupled plasma mass spectrometry, and assessed
neurodevelopment using the Bayley Scales of Infant Development-II. Associations between manganese and mental (MDI) and psychomotor (PDI) de-
velopment indices were estimated in multivariable models. Placental transfer, approximated by cord/maternal manganese ratio, cord/total manganese
ratio (total =maternal + cord), and by joint classiﬁcation according to high or low (above or below median) maternal and cord manganese, was eval-
uated as a predictor of neurodevelopment.
RESULTS:Median levels [interquartile ranges (IQR)] of manganese in maternal and cord blood, respectively, were 24:0 ð19:5–29:7Þ and 43:1 ð33:5–
52:1Þ lg=L. Adjusting for lead, arsenic, and other potential confounders, an IQR increase in maternal manganese was associated with −3:0 (95% CI:
−5:3, −0:7) points on MDI and −2:3 (95% CI: −4:1, −0:4) points on PDI. Cord manganese concentrations were not associated with neurodevelop-
ment scores. Cord/maternal and cord/total manganese ratios were positively associated with MDI [cord/maternal: b=2:6 ð95%Cl: −0:04, 5:3Þ; cord/
total: b=22:0 ð95%Cl: 3:2, 40:7Þ] and PDI (cord/maternal: b=1:7 ð95%Cl: −0:5, 3:9Þ; cord/total: b=15:6 ð95%Cl: 0:3, 20:9Þ). Compared to
mother–child pairs with low maternal and cord manganese, associations with neurodevelopment scores were negative for pairs with either high mater-
nal, high cord, or high maternal and cord manganese.
CONCLUSIONS: Maternal blood manganese concentrations were negatively associated with early childhood neurodevelopment scores in our study.
Findings highlight the importance of understanding maternal exposures during pregnancy and factors inﬂuencing placental transfer. https://doi.org/
10.1289/EHP925
Introduction
Manganese (Mn) is a trace essential element, necessary for physi-
ologic processes such as neuronal function (Prohaska 1987; Sloot
and Gramsbergen 1994), protein and energy metabolism, bone
growth (Aschner and Aschner 2005; Hurley 1981), and enzyme
activation (Erikson and Aschner 2003). During fetal and neonatal
development, there is an increased need for manganese due to its
critical role in brain function and skeletal development (Hurley
1981). Manganese crosses the placenta via active transport (Yoon
et al. 2009), likely reﬂecting fetal nutrient demand. However,
excess or accumulated manganese exposure can be neurotoxic
and has been associated with deﬁcits in cognition and motor
function (Sanders et al. 2015; Zoni and Lucchini 2013). Little is
known about how manganese transfer from the mother is regu-
lated. The way in which manganese is partitioned in the mater-
nal/fetal unit may be an important factor in fetal development
(Kopp et al. 2012).
Concerns about heightened potential sensitivity to manganese
neurotoxicity during fetal and early life compared to adulthood
have recently been raised. Research is complicated by the
increased fetal demand for manganese during development, as
well as the unique physiology of the fetus and infant in which
rapid growth makes it susceptible to nutrient deﬁciency.
Increasing maternal blood manganese levels during pregnancy
may by a physiologic response to this fetal demand, but the opti-
mal range of manganese levels has not been determined and it
remains unclear at what level maternal blood manganese may
become harmful to the fetus. Manganese crosses the blood–brain
barrier in the fetus at a higher rate than in adults, based on animal
experimental data (Cahill et al. 1980; Kostial et al. 1978; Takeda
et al. 1999). Because of the developing brain’s high oxygen and
energy consumption, it is sensitive to oxidative stress and damage
from free radicals that can result from elevated manganese expo-
sure (Blomgren and Hagberg 2006; Buonocore et al. 2001;
Ikonomidou and Kaindl 2011). Given that neurodevelopment
occurs as a cascade of well-timed, regulated events, exposure to
toxic insults can cause damage at any stage, which may impair
subsequent processes and result in developmental disability
(Nowakowski and Hayes 1999).
Environmental manganese exposure has been associated with
various neurodevelopmental outcomes among school-age chil-
dren (Bouchard et al. 2011; Khan et al. 2012; Oulhote et al.
2014a; Wasserman et al. 2006; Wright et al. 2006). Relatively
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few studies, however, have evaluated neurotoxic eﬀects of prena-
tal manganese exposure. An umbilical cord serum manganese
concentration greater than 5:0 lg=L was associated with poorer
performance on neurobehavioral tests in a population-based study
of 933 3-d-old neonates in China (Yu et al. 2014). An inverted
U-shaped association was reported between maternal blood man-
ganese at delivery and mental and psychomotor development
scores among 232 6-mo-old Korean infants with no known expo-
sure source (Chung et al. 2015). Prenatal exposure estimated in
deciduous teeth was not associated with mental and psychomotor
development scores among 197 six- to 12-mo-old Mexican-
American children living in an agricultural area of California
where use of Mn-containing fungicides is common (Gunier et al.
2015). In the same cohort, prenatal tooth manganese was associ-
ated with poorer behavioral scores in 248 school-age children,
but positively associated with scores on tests of memory and cog-
nition (Mora et al. 2015). High (>75th percentile) cord blood
manganese concentrations were associated with worse cognitive,
language, and overall neurodevelopment scores among 230 2-y
old Taiwanese children with no known exposure source (Lin
et al. 2013). Cord blood manganese levels were inversely associ-
ated with performance on psychomotor tests among 126 3-y-olds
in France, whereas no association was observed with maternal
blood manganese (Takser et al. 2003). Most prior studies, except
Takser et al. (2003), relied on a single biomarker of prenatal man-
ganese exposure, typically cord blood or serum.
Our study examines associations between prenatal manganese
exposure and neurodevelopment among young children living
near a former mining area in rural Oklahoma. The objectives
were a) to estimate associations of manganese, measured in
paired maternal–infant blood samples, with neurodevelopment at
2 y of age while adjusting for exposures to other metals; and b) to
explore the role of placental transfer of manganese as a predictor
of neurodevelopment.
Methods
Study Participants
Subjects were participants in a prospective birth cohort study of
biologic markers of fetal and early childhood exposure to metals,
maternal psychosocial stress, and their impact on neurodevelop-
ment. This research was conducted in the area of the Tar Creek
Superfund site in Ottawa County, Oklahoma. This Superfund
site, a former lead and zinc mining area, contains numerous piles
of mine waste enriched in metals that are dispersed throughout
the region (ATSDR 2004; Schaider et al. 2007). Study location
and objectives have been described elsewhere (Ettinger et al.
2009; Zota et al. 2009). Brieﬂy, pregnant women were recruited
during prenatal visits or at delivery from the Integris Baptist
Medical Center in Miami, Oklahoma. Mothers and oﬀspring
were followed until children were 7 y of age. Eligibility criteria
included a) giving birth at Integris Hospital; b) intention to live
within the study area for the next 2 y; c) not being currently en-
rolled in the study with another child; and d) having English-
language proﬁciency suﬃcient to participate in the informed con-
sent process. Eligible mothers received a detailed explanation of
study procedures before consenting to participate. The research
protocol was approved by the human subjects committees of
Integris Baptist Medical Center and Harvard T.H. Chan School
of Public Health (HSPH).
The original cohort included 713 mother–infant pairs, who
were enrolled between 2002 and 2011. Biomarkers of prenatal
manganese exposure data were available for 637 mother–infant
pairs (5 pairs missing blood samples; 71 pairs excluded to avoid
batch eﬀects inherent in diﬀerent instruments due to our
laboratory’s purchase of a new ICP-MS instrument near the end
of the study). Neurodevelopment test scores at 2 y of age were
available for 225 of these 637 pairs. One subject was excluded
from this analysis due to scores that were more than 3 standard
deviations below the expected means for both mental and psy-
chomotor development, necessitating referral for intervention.
A total of 224 mother–infant pairs were included in this
analysis.
Prenatal Manganese Exposure Assessment
Prenatal exposure to manganese was estimated by measuring
manganese concentrations in maternal blood and umbilical cord
blood samples collected at the time of birth ( ± 12 hr). Blood col-
lection procedures have been detailed elsewhere (Ettinger et al.
2009). Brieﬂy, venous whole blood from mothers and umbilical
cord blood from the umbilical vein were collected in trace ele-
ment–free tubes [BD Vacutainer royal blue top, with K2EDTA
#368381 (Becton Dickinson)] following routine clinical proce-
dures by delivery room staﬀ and shipped frozen to the Trace
Metals Laboratory at HSPH (Boston, MA). One milliliter of
blood was digested with concentrated HNO3 acid, followed by
the addition of hydrogen peroxide and dilution with deionized
water. We measured total manganese concentrations in blood
with a dynamic reaction cell–inductively coupled plasma mass
spectrometer (DRC-ICP-MS; Elan 6,100; PerkinElmer, Norwalk,
CT) using previously published methods and quality control
measures (Chen et al. 1999; Ettinger et al. 2009). Average recov-
ery of quality control standards for manganese (NIST 1643e, 1
ppb CV, human hair GBW 07601) was 96–104%. Lead and ar-
senic concentrations were also measured in blood samples and
considered as covariates in all analyses given their co-occurrence
in environmental media at this site (Zota et al. 2011). The limit of
detection (LOD) was 0:02 lg=dL for manganese, lead, and ar-
senic. All manganese and arsenic measurements were above the
LOD. Three (1.3%) lead measurements in cord blood were below
the LOD and were assigned a value of one-half the LOD.
Child Neurodevelopment Assessment
Child neurodevelopment was assessed at 2 y of age using the
Bayley Scales of Infant Development-II (Bayley 1993). Age-
adjusted scores from the Mental Development Index (MDI) and
the Psychomotor Development Index (PDI) were used as the pri-
mary outcomes. Two trained study personnel administered the
test using a standardized protocol and were overseen by a li-
censed psychologist (D.C.B.) and a graduate student clinical de-
velopmental psychologist. All study testers were blinded to the
participants’ exposure information.
Covariate Assessment
We used interviewer-administered questionnaires at the time of
enrollment to collect information on sociodemographic character-
istics, including maternal education, race/ethnicity, and smoking
and alcohol consumption during pregnancy, as well as potential
sources of metals exposure. Information on child’s birth weight,
head circumference, and gestational age at birth was abstracted
from medical records. Gestational age at birth was based on clini-
cal assessment using data from the last menstrual period, the ﬁrst
accurate ultrasound examination during the ﬁrst trimester, and
clinical examination (ACOG 2014). Hemoglobin and hematocrit
concentrations were measured in a maternal blood sample col-
lected within 12 hr of admission to labor and delivery according
to routine clinical procedures (as well as an extra tube collected
at this time for measurement of blood manganese). Maternal IQ
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was assessed using the Kaufman Brief Intelligence Test (KBIT)
at 6-mo postpartum (Kaufman and Kaufman 1990).
Statistical Analysis
Distributional plots were examined and descriptive statistics were
calculated for all variables. Bivariate associations were calculated
between all exposures, outcomes, and covariates. The correlation
between maternal and cord blood manganese was estimated using
Spearman’s r correlation coefficient. Characteristics of mother–
infant pairs included in all analyses were compared to those
excluded from analyses using t-tests for continuous variables and
chi-square tests for categorical variables.
We estimated associations between prenatal manganese con-
centrations and neurodevelopment using multivariable regression.
We examined potential nonlinear associations betweenmanganese
and neurodevelopment using generalized additive models with
penalized splines (constrained to 4 knots).We used a likelihood ra-
tio test comparing models with a smoothed manganese term to
models with a linearmanganese term to assess linearity of theman-
ganese–neurodevelopment association. To address skewness, we
used natural logarithmic-transformed metals concentrations in ex-
posure–neurodevelopment models. We modeled manganese con-
centrations as continuous loge-transformed concentrations and
compared the 25th to 75th percentile [interquartile range (IQR)].
Neurodevelopment test scores were normally distributed and ana-
lyzed as continuous variables.
Potential confounders were selected a priori based on previ-
ous literature and on established or plausible associations with
neurodevelopment (Grandjean and Landrigan 2006; Lanphear
et al. 2000; Tong et al. 2007). We included child sex, maternal
education (≥12th grade vs:<12th grade), maternal IQ, maternal
hemoglobin at time of delivery (g/dL), and concentrations of
maternal or cord blood lead and arsenic, centered at the mean of
the loge distribution and modeled as penalized splines (con-
strained to 4 knots). Maternal hemoglobin was used as a proxy
for iron status, which is a potential confounder given that iron
deﬁciency in the neonate can adversely impact neurodevelopment
(Georgieﬀ 2008) and that iron status may inﬂuence manganese
levels (Gunshin et al. 1997). In sensitivity analyses, we consid-
ered the following additional potential confounders because they
were associated with loge-transformed blood manganese levels
or neurodevelopment scores in bivariate models (p<0:10):
maternal smoking during pregnancy (yes/no), gestational age at
birth (weeks), maternal age at time of delivery (years), ﬁrst-born
child (yes/no), annual household income ($20,000–40,000,
>$40,000 vs:<$20,000), maternal marital status (married/living
with partner vs. never married/separated/divorced), and use of
prenatal vitamins. Given the recent emphasis on sex-speciﬁc
metal eﬀects (Llop et al. 2013) and possible sex-related metabolic
diﬀerences in manganese regulation (Oulhote et al. 2014b),
we explored sex diﬀerences in the association between manga-
nese and neurodevelopment by including an interaction term
(child sex manganese) in regression models.
Some participants were missing data on one or more key
potential confounders (i.e., maternal IQ, maternal hemoglobin,
maternal and cord arsenic levels). We used multiple imputation
to impute missing values using chained equations with the MI
procedure in SAS (SAS Institute Inc., Cary, NC, USA) (van
Buuren 2007; White et al. 2011). We assumed data were missing
at random, that is, that the missingness did not depend on the
unobserved data. We generated 40 imputed data sets. In the im-
putation process, we included all exposure and outcome variables
and covariates thought to be related to the process causing the
missing data (see Table S1, for a list of variables). We combined
results from models ﬁt with the multiply imputed data sets by
applying Rubin’s formula (Rubin 2004) in R (R Foundation for
Statistical Computing).
We explored the hypothesis that the eﬃciency with which
manganese is transferred from mother to fetus is an important de-
terminant of neurodevelopment, as has been posited previously
(Kopp et al. 2012). We evaluated cord/maternal blood manganese
ratio as well as cord/total blood manganese ratio (total =
maternal+ cordmanganese) as predictors of neurodevelopment.
Ratios were calculated using untransformed manganese concen-
trations. We also clustered mother–infant pairs into four groups,
based on blood manganese concentrations dichotomized at the
medians of the two distributions: a) low maternal/low cord, rep-
resenting concordant low exposures; b) low maternal/high cord;
c) high maternal/low cord; and d) high maternal/high cord, repre-
senting concordant high exposures. Using multivariable regres-
sion models, we estimated the associations between this
categorical variable, a crude representation of placental transfer,
and neurodevelopment. Models with ratios and with clustered
mother–infant pairs were adjusted for the same set of a priori
covariates as manganese–neurodevelopment models (i.e., child
sex, maternal education, maternal IQ, maternal hemoglobin at
time of delivery, and concentrations of maternal or cord blood
lead and arsenic).
We conducted sensitivity analyses to evaluate the robustness
of our ﬁndings. a) We ran models using complete cases only and
compared results with those using the imputed datasets. b) We
examined the inﬂuence of extreme values of prenatal manganese
concentrations by ﬁtting models with and without outliers identi-
ﬁed using the generalized extreme Studentized deviate (ESD)
many-outlier procedure, set to identify up to 10 outliers (Rosner
1983). c) We examined the potential confounding eﬀects of addi-
tional sociodemographic characteristics (listed above) by re-
running models including these variables. For all statistical tests,
the signiﬁcance level was set at 5%. We conducted statistical
analyses using SAS (version 9.4; SAS Institute Inc.) and R (ver-
sion 3.1.2; R Foundation for Statistical Computing).
Results
Table 1 shows characteristics of mother–infant pairs included in
all analyses, as well as those excluded from analyses due to miss-
ing exposure and/or neurodevelopment data. Included pairs
(n=224) diﬀered from excluded pairs (n=489) on several
characteristics: mothers included were older at time of delivery,
had higher household incomes, were more likely to be married/
living with partner and have at least a high school education,
had higher blood arsenic levels, and were less likely to have
smoked or have had smokers in the household during preg-
nancy. For study participants, the average age±SD at time of
neurodevelopment assessment was 2:1± 0:1 y. MDI scores
ranged from 54 to 128 (mean±SD=98:8±15:9); PDI scores
ranged from 57 to 133 (mean±SD=105:3± 12:2). Among
included pairs, characteristics of participants with complete
data on all variables included in the imputation process
(n=122) were similar to those of participants with incomplete
data (n=102; see Table S2).
Median (25–75th percentile) manganese concentrations in
maternal and cord blood were, respectively, 24:0 ð19:5–29:7Þ and
43:1 ð33:5–52:1Þ lg=L. The median manganese concentration in
cord blood was nearly twice the median concentration in mater-
nal blood, and the median (25–75th percentile) cord/maternal
manganese ratio was 1.8 (1:4–2:3). Manganese levels were in
the range of levels reported in other studies of mother–infant
pairs (Figure 1). Maternal and cord blood manganese levels
were correlated (Spearman rho= 0:39, p<0:0001, n=224),
though in a nonlinear manner (Figure 2). At maternal
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manganese less than 40 lg=L, cord manganese level increased
by an estimated 1:1 ½95% confidence interval ðCIÞ: 0:8, 1:4lg=L
for each 1-lg=L increase in maternal manganese. At maternal
manganese levels greater than 40 lg=L, however, a negative
association was apparent, although the estimated curve is
imprecise in this range because it is based on a limited num-
ber of observations (n=18).
Therewas a lack of evidence for a departure from linearity in the
associations between loge-transformedmaternal manganese levels
and neurodevelopment scores, based on likelihood ratio tests and
visual inspection (Figure 3A,B). Maternal manganese was signiﬁ-
cantly negatively associatedwith bothmental and psychomotor de-
velopment (Table 2): an interquartile range increase in maternal
manganese (10:1 lg=L) was associated with decreases of 3.0 (95%
CI: −5:3, −0:7) and 2.3 (95% CI: −4:1, −0:4) points in MDI and
PDI scores, respectively.
Visual inspection of smoothed plots of loge-transformed cord
blood manganese with neurodevelopment suggest an increase in
MDI and PDI scores at lower concentrations and a leveling oﬀ at
mid-range concentrations (Figure 3C,D). However, there was a
lack of evidence for a departure from linearity based on likelihood
ratio tests comparingmodels with penalized spline terms to models
with linear terms (MDI: p=0:15; PDI: p=0:12). There were no
signiﬁcant associations between loge-transformedcord bloodman-
ganese andMDI or PDI scores (Table 2). Results from exploratory
analyses of sex-speciﬁc manganese associations, in which we
included an interaction term (child sex manganese) in regression
models,were inconclusive (seeTableS3).
We modeled associations between neurodevelopment and
three proxy measures of the eﬃciency of placental transfer. In
multivariable adjusted models of cord/maternal blood manganese
ratio and cord/total blood manganese ratio (total =maternal +
cordmanganese), MDI and PDI scores were positively associated
with both ratios [cord/maternal-MDI: b=2:6 (95% CI: −0:04,
5.3); cord/maternal-PDI: b=1:7 (95% CI: −0:5, 3.9); cord/total-
MDI: b=22:0 (95% CI: 3.2, 40.7); cord/total-PDI: b=15:6 (95%
CI: 0.3, 20.9)]. Based on the analysis of clustered mother–infant
pairs, pairs with high maternal manganese only (i.e., maternal
manganese levels≥median), high cord manganese only, or high
maternal and high cord manganese had lower neurodevelopment
scores, compared to mother–child pairs with low maternal and low
cord manganese levels (Table 3). PDI scores were signiﬁcantly
Table 1. Descriptive characteristics of included versus excluded Tar Creek mother–infant pairs.
Characteristics
Included (n=224)a Excluded (n=489)b
n ð%Þ Mean±SD or Median (IQR) Range n ð%Þ Mean±SD or Median (IQR) Range
Prenatal exposure measures, median, IQRc
Maternal blood Mn (lg=L) 224 24:0 ð19:5–29:7Þ 8:0–117:4 484 22:5 ð18:6–29:0Þ 8:8–80:9
Maternal blood Pb (lg=dL) 224 0:6 ð0:4–0:9Þ 0:06–3:0 484 0:6 ð0:4–0:9Þ 0:03–3:1
Maternal blood As (lg=L)* 222 1:8 ð1:1–2:8Þ 0:2–8:2 482 1:4 ð0:9–2:2Þ 0:1–24:1
Cord blood Mn (lg=L) 224 43:1 ð33:5–52:1Þ 5:4–139:1 481 41:2 ð32:1–51:9Þ 8:5–104:5
Cord blood Pb (lg=dL) 224 0:4 ð0:3–0:6Þ 0:01–3:9 481 0:4 ð0:3–0:6Þ 0:03–4:9
Cord blood As (lg=L) 221 2:3 ð1:7–3:3Þ 0:2–10:6 474 2:4 ð1:8–3:5Þ 0:1–29:0
Child characteristics
Female sex 91 (40.6) 234 (48.1)
First-born child 86 (38.6) 189 (38.7)
Birth weight (g), mean± SD 224 3,404:7± 477:1 2,296–4,874 486 3,331:8± 472:0 1,361–4,734
Gestational age at birth (weeks), mean±SD 224 39:0± 1:3 34–41 483 39:1± 1:4 26–42
Preterm birth (<37wk) 9 (4.0) 24 (5.0)
Head circumference at birth (cm), mean±SD 215 34:6± 1:8 27:9–40:6 467 34:4± 1:7 26:7–43:2
Delivery type: cesarean sectiond 64 (29.8) 120 (25.4)
Maternal characteristics
Marital status: married or living with partner* 174 (77.7) 281 (59.4)
Education: ≥12th grade* 191 (85.3) 335 (68.9)
Smoked during pregnancy: yes* 56 (25.0) 190 (38.9)
Any smokers in household: yes* 50 (28.3) 116 (45.5)
Race/Ethnicity
White 154 (69.4) 312 (66.2)
Native American 52 (23.4) 115 (24.4)
Other (including Hispanic) 16 (7.2) 44 (9.3)
Annual household income*
<$20K 59 (37.3) 174 (55.6)
$20K–$40K 54 (34.2) 99 (31.6)
$40K–$70K 37 (23.4) 31 (9.9)
>$70K 8 (5.1) 9 (2.9)
Hemoglobin at delivery, mean±SD 220 11:7± 1:4 6:6–15:7 481 11:8± 1:3 3:6–17:2
Anemia at delivery: yese 56 (25.4) 119 (24.7)
Use of prenatal vitamins: yes* 147 (65.6) 282 (57.7)
Age at delivery (years), mean±SD* 224 25:8± 5:8 14–43 486 23:9± 5:2 15–44
IQ, mean±SD 186 101:8± 17:3 52–135 120 99:6± 14:3 62–134
Note: Individuals included in analysis differed from excluded individuals, p<0:05. t-tests were conducted on loge-transformed blood metals concentrations.
aNumbers may not sum to total sample size (n=224) for some characteristics due to missing data: first-born child n=1, delivery type n=9, household smokers n=47, race/ethnicity
n=2, income n=66, anemia n=4. Percentages are based on observations with known values only.
bNumbers may not sum to total sample size (n=489) for some characteristics due to missing data: sex n=2, first-born child n=1, marital status n=16, education n=3, prenatal
smoking n=1, household smokers n=234, race/ethnicity n=18, income n=176, anemia n=8. Percentages are based on observations with known values only. Participants excluded
from analyses due to missing blood samples (n=5), new ICP-MS instrument error (n=71), missing outcome data (n=412), and neurodevelopment scores more than 3 SD below
expected mean (n=1).
cMedian and interquartile range (IQR, 25–75Th percentiles) reported for blood metals concentrations.
dCompared to vaginal or vaginal assisted delivery.
eAnemia at delivery defined as maternal hemoglobin <11:0 g=dL at delivery, which is based on the definition from the Centers for Disease Control and Prevention (during 3rd trimes-
ter), the World Health Organization (during pregnancy), and the American Congress of Obstetricians and Gynecologists (in 1st and 3rd trimesters; ACOG 2014).
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lower among pairs in all three groups, compared to the low con-
cordant exposure group.
Sensitivity Analyses
Sensitivity analyses produced three main ﬁndings. a) Results
from models of maternal and cord manganese with neurodevelop-
ment using complete cases only were similar to results of analy-
ses that included imputed data (Table 2). Adjusted associations
between neurodevelopment and joint classiﬁcation of maternal–
infant groups according to high or low (above or below median)
maternal and cord manganese were also similar when based only
on complete cases (Table 3). b) Three subjects were identiﬁed
with outlying blood manganese levels (two maternal: 73.2,
117:4 lg=L; one cord: 139:1 lg=L; Figure 2) using the general-
ized ESD many-outlier procedure. When these subjects were
excluded, associations between manganese and neurodevelop-
ment remained similar (Table 2), indicating that the few outlying
manganese levels did not drive the associations we observed.
Further, the correlation between maternal and cord manganese
was unchanged (Spearman rho= 0:40, p<0:0001, n=221 vs.
for all observations: Spearman rho= 0:39, p<0:0001, n=224)
and a nonlinear pattern remained (Figure 2). c) With adjustment
for additional sociodemographic variables, conclusions were
unchanged (Table 2).
Discussion
We estimated inverse linear associations between loge-
transformed maternal blood manganese and early childhood men-
tal and psychomotor development scores. Our ﬁndings are gener-
ally consistent with other studies that have estimated associations
between biomarkers of prenatal manganese and neurodevelop-
mental outcomes (Lin et al. 2013; Takser et al. 2003; Yu et al.
2014). Our study is unique in that it is among the ﬁrst to evaluate
neurodevelopment outcomes in association with both maternal
and infant biomarkers of manganese exposure, and with proxy
measures of manganese placental transfer. To our knowledge,
only one other study has estimated both maternal and cord blood
eﬀects: Takser et al. (Takser et al. 2003) observed inverse associ-
ations between cord, but not maternal, blood manganese and
Figure 1. Comparison of median blood manganese concentrations in maternal–infant pairs by study. Maternal levels measured in blood collected near time of
delivery; infant levels measured in umbilical cord blood.
Figure 2. Scatter plots with Loess smoother of maternal blood manganese
(lg=L) and cord blood manganese (lg=L). (A) All observations. Spearman
rho= 0:39, p<0:0001 ðn=224Þ; (B) Excluding manganese outliers (two
maternal: 73.2, 117:4 lg=L; one cord: 139:1 lg=L). Spearman rho= 0:40,
p<0:0001 ðn=221Þ.
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performance on psychomotor subscales of the McCarthy Scales
of Children’s Abilities among 126 3-y-olds with prenatal bio-
marker levels similar in magnitude to our study [geometric mean
(range) 20:4 lg=L ð6:3–151:2Þ and 38:5 lg=L ð14:9–92:9Þ in
maternal and cord blood samples, respectively]. In contrast, we
found that maternal, but not cord, blood manganese was associ-
ated with neurodevelopment, as indicated by lower mean MDI
and PDI scores, in our study population. Other studies have also
reported evidence of adverse eﬀects of cord blood manganese
(Lin et al. 2013; Yu et al. 2014), although maternal biomarkers
were not assessed.
Median blood manganese levels in our U.S.-based cohort
were lower than median values reported for children in China
(Chen et al. 2014), but higher than median or mean values
reported for study cohorts in Germany, France, South Africa, and
Canada (Abdelouahab et al. 2010; Chen et al. 2014; Kopp et al.
2012; Rudge et al. 2009; Takser et al. 2004). In this cohort, the
routes of exposure likely include ingestion of manganese in dusts.
We have previously reported positive associations between child
hair manganese levels and house dust, but not indoor air, yard
soil or tap water, in a subset of this cohort (Zota et al. 2015). Our
observation that the median manganese level in cord blood was
about twice as high as in maternal blood likely reﬂects active
transport of manganese across the placenta (Krachler et al.
1999; Nandakumaran et al. 2016). Our ﬁnding is similar to pre-
vious reports in whole blood from 62 mother–infant pairs in
South Africa (median 16:8 lg=L and 34:9 lg=L in maternal and
cord blood samples, respectively) (Rudge et al. 2009) and in
Figure 3. Smoothed associations between blood manganese and child neurodevelopment. Generalized additive models with penalized splines (constrained to 4
knots), adjusted for child sex, maternal education, maternal IQ, maternal hemoglobin, and smoothed loge blood lead and arsenic (centered). Models use com-
plete case method (n=181). (A) Maternal blood manganese with MDI; (B) maternal blood manganese with PDI; (C) cord blood manganese with MDI; (D)
cord blood manganese with PDI.
Table 2. Adjusted associations of prenatal manganese biomarkers with neurodevelopment.
Models
Outcome: MDI Outcome: PDI
n b 95% CI n b 95% CI
Models with loge maternal blood manganese
a
Using imputed data 224 −3:0 −5:3, −0:7 224 −2:3 −4:1, −0:4
Using complete case method 181 −2:9 −5:5, −0:3 181 −1:6 −3:7, 0:5
Using imputed data, excluding outliersb 221 −2:7 −5:2, −0:2 221 −2:4 −4:4, −0:4
Using imputed data, adjusting for additional potential confoundersc 224 −2:9 −5:3, −0:4 224 −2:3 −4:3, −0:3
Models with loge cord blood manganese
a
Using imputed data 224 0.5 −1:8, 2:8 224 −0:1 −1:9, 1:8
Using complete case method 181 0.8 −1:8, 3:4 181 0.9 −1:2, 3:0
Using imputed data, excluding outliersb 221 0.1 −2:3, 2:5 221 −0:2 −2:1, 1:7
Using imputed data, adjusting for additional potential confoundersc 224 1.2 −1:8, 3:6 224 0.3 −1:7, 2:2
Note: Adjusted for child sex, maternal IQ, maternal education, maternal hemoglobin, and smoothed loge blood Pb and As (centered) in maternal or cord blood.
aScaled to difference between 25th and 75th percentile of blood Mn (maternal: 10:1 lg=L; cord: 18:5 lg=L).
bOutlying manganese levels in maternal blood: 73.2, 117:4 lg=L; cord blood: 139:1 lg=L.
cAdditionally adjusted for maternal smoking during pregnancy, gestational age at birth, maternal age at time of delivery, first-born child, annual household income, maternal marital
status, and prenatal vitamin use.
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serum from 202 mother–infant pairs in China (median 2:8 lg=L
and 4:0 lg=L in maternal and cord serum samples, respectively)
(Yu et al. 2013). The Spearman correlation coeﬃcient we
observed between maternal and cord blood manganese was in
the range of correlation coeﬃcients reported by other studies
(Abdelouahab et al. 2010; Chen et al. 2014; Gunier et al. 2014;
Takser et al. 2004; Yu et al. 2013), though few studies appear to
have allowed for possible nonlinearity (Chen et al. 2014; Gunier
et al. 2014).
Our observation that the concentration of manganese in
maternal blood, despite generally being lower than the concentra-
tion in cord blood, was a stronger predictor of neurodevelopment
was unexpected, and the explanation is not apparent. We
hypothesized that cord blood would more proximally represent
fetal exposure, and therefore be more strongly associated with
neurodevelopment. However, given that manganese is a nutrient,
relationships are diﬃcult to predict.
It is possible that high maternal manganese levels produce
adverse eﬀects on the placenta that are subsequently responsible
for poorer neurodevelopment. This might explain diﬀerences in
results compared to cord blood manganese. The fetus may be pro-
tected from direct adverse eﬀects of excess maternal manganese
by accumulating manganese in the placenta, but it may be indi-
rectly aﬀected by maternal manganese via placental factors that
regulate neurodevelopment. An in vitro human placenta study
has demonstrated that during normal steady-state exposure, the
placenta eﬃciently transfers manganese to the fetus, but at high-
dose maternal exposure the placenta limits transfer to the fetal
circulation and accumulates manganese (Miller et al. 1987). This
is consistent with the nonlinear relationship we observed between
maternal and cord blood manganese levels, whereby levels were
positively associated up to approximately 40 lg=L maternal
blood, and cord blood levels subsequently leveled oﬀ or declined.
There was, however, a relatively small number of observations in
this higher exposure range. Alternative explanations may include
mechanisms that do not involve a causal eﬀect of maternal man-
ganese, and ﬁndings should be conﬁrmed in other studies.
Several biological mechanisms for the neurotoxic eﬀects of
prenatal manganese exposure have been proposed. Animal stud-
ies have reported that maternal developmental exposure in mice
aﬀects neurogenesis in the oﬀspring, altering the number of
immature granule cells in the hippocampal dentate gyrus and
causing neuronal mismigration (Ohishi et al. 2012; Wang et al.
2012). In an experimental study, in utero exposure altered epige-
netic gene regulation in oﬀspring, which may aﬀect programing
of cells involved in neurogenesis (Wang et al. 2013). Manganese
neurotoxicity appears to involve oxidative stress and dopami-
nergic dysfunction (Racette et al. 2012), and a link to adverse
neurodevelopmental outcomes through disruption of thyroid
homeostasis following alterations to dopamine activity has also
been proposed (Soldin and Aschner 2007).
In our exploration of placental transfer, we found that MDI
and PDI scores increased as the cord/maternal or cord=
ðmaternal + cordÞ manganese ratios increased, suggesting that
increasing cord manganese levels relative to maternal levels or
relative to total (i.e., cord+maternal) levels might be beneﬁcial.
We also found that both MDI and PDI scores were lower among
mother–infant pairs with either high maternal levels or high cord
levels, compared to mother–infant pairs with both low maternal
and low cord manganese. Overall, these results are consistent
with our ﬁnding of a negative association between maternal man-
ganese levels and scores for cognition and psychomotor function
at 2 y of age. Further study is necessary, but these preliminary
ﬁndings suggest that not only are concentrations of manganese in
maternal blood predictors of neurodevelopment, but the relative
amount of manganese transferred from maternal to fetal circula-
tion may also be important. Factors that inﬂuence manganese
transfer should be investigated more deeply.
Our study has several limitations. Prenatal maternal blood
manganese may not best represent manganese total body burden
given that it is a nutrient with a steady-state normal concentration
range that is regulated in the body, rather than a xenobiotic that
undergoes metabolism and excretion. Physiologic factors such as
genetic variability or variability in metabolic function or liver
function may contribute to diﬀerences in manganese levels
(Claus Henn et al. 2011; Zerón et al. 2011). In addition, little is
known about how maternal blood manganese levels vary during
labor and delivery; therefore, timing of blood sample collection
may inﬂuence blood manganese levels. However, blood manga-
nese levels also increase in the setting of chronic exposure. For
example, blood levels have been correlated with airborne manga-
nese levels (Smith et al. 2007), with an indicator of take-home
occupational pesticide exposure in a region where manganese-
containing pesticides are commonly applied (Gunier et al. 2014),
and with MRI intensity index in the globus pallidus among
manganese-exposed children (Kafritsa et al. 1998). Our modest
sample size limits the precision in our eﬀect estimates. However,
by multiply imputing missing covariate data, an approach that is
valid if data are missing at random, we maximized the use of
available exposure and outcome data. Finally, there is a possibil-
ity of selection bias from loss to follow up if factor(s) related to
participation are associated with both manganese levels and
neurodevelopment.
This is among the ﬁrst studies to examine both maternal and
infant biomarkers of prenatal manganese exposure in relation to
neurodevelopment, which allows for a comparison of biomarkers
as well as an exploration of placental transfer. The prospective
design of our study strengthens the growing literature on manga-
nese and neurodevelopment, which remains dominated by cross-
sectional studies that cannot establish temporality. We collected
data on a large number of potential confounders, including co-
exposures to lead and arsenic, and results were robust to addi-
tional confounder adjustment.
Conclusions
In our U.S. study population, the concentration of manganese in
maternal blood at or near the time of delivery was associated
with lower neurodevelopment scores at 2 y of age. In addition,
we found preliminary evidence suggesting that placental factors
may inﬂuence associations between prenatal manganese exposure
Table 3. Adjusted associations between neurodevelopment and joint classifi-
cation of maternal–infant groups according to high or low (above or below
median) maternal and cord manganese.
Joint classification of maternal
and cord Mn levels
Outcome: MDI Outcome: PDI
n b 95% CI n b 95% CI
Using imputed data
Low maternal, low corda 71 - - 71 - -
Low maternal, high cord 41 −3:7 −9:5, 2:1 41 −6:2 −10:8, −1:5
High maternal, low cord 41 −5:2 −11:0, 0:5 41 −7:0 −11:6, −2:3
High maternal, high cord 71 −7:2 −12:3, −2:1 71 −6:3 −10:4, −2:3
Using complete case method
Low maternal, low corda 63 - - 63 - -
Low maternal, high cord 38 −2:7 −9:0, 3:5 38 −5:4 −10:5, −0:4
High maternal, low cord 37 −5:7 −11:9, 0:5 37 −6:4 −11:4, −1:4
High maternal, high cord 43 −7:4 −13:5, −1:3 43 −4:0 −8:9, 0:9
Note: Models adjusted for child sex, maternal IQ, maternal education, maternal hemo-
globin, and smoothed loge cord blood Pb and As (centered); groups defined by maternal
and cord blood Mn levels. Low indicates <median; high indicates≥median. Median
maternal Mn=24:0 lg=L; median cord Mn= 43:1 lg=L.
aReference category.
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and neurodevelopmental outcomes. In studies of prenatal manga-
nese exposure, careful consideration should be given to the selec-
tion of biomarkers and the role of placental transfer should be
evaluated.
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